Market view: There was an atmosphere of boom in the market after the US. On the last day of the business week, the market enthusiasts remained high. Sensex, Nifty closed with a great lead. The Sensex climbed 1046 points to close at 82408, while the Nifty jumped at 319 points to 25112. In such a situation, further moves of the market and Baroda BNP Paribas MF Senior Fund Manager- Equity Jitendra Shriram while talking about Baroda BNP Paribas Large Fund (Baroda BNP Paribas Large Fund) Said that this year there was a lot of upheaval in the market. The effect of Geo-Politics Issues was seen. Along with the North-Western border, there was also tension on the Middle East. Last year’s compare was better growth this year. The impact of RBI policy will also be seen further. It takes 3 to 6 months to reset everything. There are positive signs about largecap funds.
He further said that the valuation of largecap is slightly economical. Mid and smallcap valuations are still expensive. Largecap looks more stable than the small-middle cap. Investment in largecap will benefit stability. Conservative will be the best for investors. Keep some exposure in mid-mall space as well.
Talking on Baroda BNP Paribas large cap, he said that the top 100 stocks have an exposure of up to 80%. 10% is exposure in mid-jokes. Largecap funds have a low risk. The weightage in the correct sector is necessary. Allocation occurs based on the performance of the fund. Liquidity is high in big companies. Entry- Exit is also easy, more turnover is high. While on the strategy of sector selection, he said that weightage tracking is necessary. Market growth and sector positioning, market growth eyes and sector leading growth are invested in the sector focusing on the strategy.
Focus in these sectors? Responding to this question, he said that there are opportunities for investment in the healthcare sector. We have focus in utility, consumer desire. There is an overweight view in the auto sector. Banks and financials have neutral while chemical, metal space underweight.
Giving his opinion on the healthcare sector, he said that there is a focus on the domestic pharma sector. The sector will benefit from government schemes. Ayushman Bharat, Health Insurance Scheme will be benefited. Growth in International Pharma Export is getting good. India supplies 40–45% medicine. Export oriented pharma companies are great. Hospital chain and health infrastructure space is correct. Investment in organized hospitals is good.
Talking on the banking and IT sector, he said that there were first underweight in the banking sector, now a neutral position has been created. Estimated Slodown in Nominal GDP. Due to decrease in interest rates, pressure can be seen in NIM. At the same time, the tariff did not affect the IT sector. Global slowdown may have an effect.
(Disclaimer: The ideas given on Moneycontrol.com have their own personal views. The website or management is not responsible for this. Users are advised by money control that any investment Decision Seek the advice of a sortified expert before taking.
